In strengthening Spravato sales, a positive sign for psychedelic drugs

In strengthening Spravato sales, a positive sign for psychedelic drugs

    18 Jul 2024

Dive Brief: Sales of Johnson & Johnson’s depression drug Spravato accelerated in the second...

Medical device firms have cut more than 14,000 jobs in the past 18 months

Medical device firms have cut more than 14,000 jobs in the past 18 months

    18 Jul 2024

Medical device companies have been steadily cutting jobs for the past 18 months, eliminating...

NGM, now private, raises $122M for redrawn research plans

NGM, now private, raises $122M for redrawn research plans

    17 Jul 2024

Dive Brief: NGM Biopharmaceuticals, which was taken private earlier this year, has raised $122...

Cardurion raises another $260M to fuel heart drug pipeline

Cardurion raises another $260M to fuel heart drug pipeline

    17 Jul 2024

Dive Brief: Biotechnology startup Cardurion Pharmaceuticals on Tuesday raised a $260 million Series B...

Asceneuron raises another $100M for Alzheimer’s drug development

Asceneuron raises another $100M for Alzheimer’s drug development

    16 Jul 2024

Asceneuron, a Switzerland-based biotechnology company, has raised another $100 million to support its work...

Revolution Medicines firms up Phase 3 trial plans with latest cancer drug data

Revolution Medicines firms up Phase 3 trial plans with latest cancer drug data

    16 Jul 2024

Dive Brief: An experimental cancer drug developed by Revolution Medicines shrank pancreatic tumors in...

As GLP-1 drugs boom, other healthcare companies are cashing in

As GLP-1 drugs boom, other healthcare companies are cashing in

    15 Jul 2024

The popularity of new GLP-1 drugs for weight loss is giving rise to a...

Flagship raises $3.6B for biotech investing

Flagship raises $3.6B for biotech investing

    14 Jul 2024

Dive Brief: Flagship Pioneering said Wednesday that it’s added another $3.6 billion to its...

FDA’s lab-developed test rule could be first test of agency’s power post-Chevron

FDA’s lab-developed test rule could be first test of agency’s power post-Chevron

    14 Jul 2024

The recent U.S. Supreme Court decision to overturn the Chevron doctrine could open the...

Bristol Myers’ leukemia blockbuster set to face generic rivals

Bristol Myers’ leukemia blockbuster set to face generic rivals

    13 Jul 2024

Pharmaceutical companies face a looming patent cliff over the next several years, as generic...